__________________________________________________________________________________________
Re: Global ID / Local ID: TH201412003250/ TH141201052 FU (2)
Thank you for reporting to us an adverse event related to Lilly product(s).
We would like to collect more information to better understanding the reported event.
Please respond to following question regarding the adverse event – Blood pressure was 170/100, involving a female patient, aged 74, who was subscribed Forteo, reported the event to Lilly on 04-Dec-2014.
Please provide the informatoin for following:
1. What was the reason for the hip surgery performed on 04-Dec-2014?
____________________________________________________________________________
¬¬¬¬
____________________________________________________________________________
____________________________________________________________________________
2. Did the reason for the hip surgery started before Forteo treatment?
____________________________________________________________________________
¬¬¬¬
____________________________________________________________________________
____________________________________________________________________________
3. Did the reason for the hip surgery worsened while on Forteo?
____________________________________________________________________________
¬¬¬¬
____________________________________________________________________________
____________________________________________________________________________
4. Did the patient had a medical history of hypertension?
____________________________________________________________________________
¬¬¬¬
____________________________________________________________________________
____________________________________________________________________________
5. Was the event of blood pressure increased related to Forteo?
____________________________________________________________________________
¬¬¬¬
____________________________________________________________________________
____________________________________________________________________________
HCP’s signature:
Date:
__________________________________________________________________________________
For Eli Lilly internal use only
Date of Confirmation of FU request sent to HCP:
Name and Designation: